Phenotype of large-scale expanded TIL from melanoma-invaded lymph nodes of 47 patients treated by TIL.

*<p>Melanoma patients bearing only one metastatic lymph node (early stage III patients).</p>a<p>E1 and E2 were TIL populations obtained and reinjected to the patient from respectively the first and the second ex-vivo expansions.</p>b<p>Percentages of CD-positive TIL were estimated by membrane labeling. Cells were analyzed on a FACScalibur.</p>c<p>Relapse-free survival of patients (−): patients who relapsed,(months); (+): patients who did not relapse.